Mobile

A randomised, parallel-arm, open-label trial comparing degarelix with goserelin plus anti-androgen flare protection (bicalutamide), in terms of reduction in International Prostate Symptom Score (IPSS)...

Update Il y a 5 ans
Reference: EUCTR2008-004338-26

A randomised, parallel-arm, open-label trial comparing degarelix with goserelin plus anti-androgen flare protection (bicalutamide), in terms of reduction in International Prostate Symptom Score (IPSS), in patients with lower urinary tract symptoms (LUTS) secondary to locally advanced prostate cancer

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

To demonstrate that LUTS relief with degarelix is non-inferior to goserelin plus bicalutamide, based on a reduction in IPSS at 12 weeks as compared to baseline.

Inclusion criteria

  • Prostate cancer

Links